At an industry level, our long-term stance remains cautious. The nondiscretionary nature of pharmaceuticals and other health-related products, coupled with ageing of the general population, implies ...

During the forecast period, the global silver nitrate market is anticipated to generate profitable growth opportunities, with ...

Sigma Healthcare (ASX: SIG) shares dipped as much as 6% in early trade after its first-half 2024 results missed analyst ...

The firm is likely to pay as much as $100 million to settle a probe of a trading scandal.